The reactivity of NH(2)BH(2) in the presence of ammonia-borane (AB) is investigated using ab initio CCSD(T) simulations to answer the following three questions: How do AB and NH(2)BH(2) react? How do aminoborane species oligomerize apart from catalytic centers? Can the formation of experimentally observed products, especially cyclic N(2)B(2)H(7)-NH(2)BH(3), be explained through the kinetics of NH(2)BH(2) oligomerization in the presence of AB? AB is shown to react with NH(2)BH(2) by the addition of NH(3)-BH(3) across the N=B double bond, generating linear NH(3)BH(2)NH(2)BH(3). This species decomposes by surmounting a reasonable barrier to produce two NH(2)BH(2) and H(2). The generation of additional NH(2)BH(2) from NH(2)BH(2) and AB provides a pathway for autocatalytic NH(2)BH(2) production. The important intermediates along the oligomerization pathway include cyclic (NH(2)BH(2))(2) and linear NH(3)BH(2)NH(2)BH(3), both of which have been observed experimentally. Calculations show cyclic N(2)B(2)H(7)-NH(2)BH(3), an aminoborane analogue of ethylcyclobutane, to be the kinetically preferred stable intermediate resulting from oligomerization of free NH(2)BH(2) over its isomers, cyclic B(2)N(2)H(7)-BH(2)NH(3) and cyclotriborazane, cyclic (NH(2)BH(2))(3). Simulations show cyclotriborazane formation to be kinetically slower than cyclic B(2)N(2)H(7)-NH(2)BH(3) formation and imply that formation of the cyclic species cyclotriborazane and cyclopentaborazane may be catalyzed by binding of NH(2)BH(2) to a catalytic metal center. Routes that may lead to larger noncyclic oligomers are suggested to be kinetically competitive. The highly reactive N=B double bonds of NH(2)BH(2) are shown to be of central importance in understanding aminoborane oligomerization.
No takes yet. Share an insight, caveat, or question.
Zimmerman et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: